Soft Tissue Repair Implants with Hydroxybutyrate Antimicrobial Properties
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Soft tissue repair implants face challenges in reducing infection risk during surgical implantation, as the process can expose patients to pathogens.
Innovation Solution
Incorporating hydroxybutyrate and/or its conjugate acid into soft tissue repair implants to provide antimicrobial properties, reducing or preventing microbial infection.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If hydroxybutyrate and/or its conjugate acid are incorporated into soft tissue repair implants, then antimicrobial properties are provided and microbial infection is reduced or prevented, but the device complexity increases due to the additional antimicrobial component
Solution Approach 1:
The patent combines the structural function of the soft tissue repair implant with the antimicrobial function of hydroxybutyrate and/or its conjugate acid into a single integrated device. The antimicrobial agent is incorporated directly into the implant material itself, allowing the implant to simultaneously provide mechanical support and prevent microbial infection without requiring separate antimicrobial components or procedures
Solution Approach 2:
The patent creates a composite material system by integrating hydroxybutyrate and/or its conjugate acid with the soft tissue repair implant material. This composite structure combines the biocompatible, infection-preventing properties of hydroxybutyrate with the structural characteristics of the implant material, achieving both mechanical support and antimicrobial protection in a unified material system
Data Source
AI summary
Articles and methods involving soft tissue repair implants comprising 2-hydroxybutyrate, 3-hydroxybutyrate, 4-hydroxybutyrate, and/or their conjugate acids are generally provided. The 2-hydroxybutyrate, 3-hydroxybutyrate, 4-hydroxybutyrate, and/or the conjugate acid(s) of 2-hydroxybutyrate, 3-hydroxybutyrate, and 4-hydroxybutyrate may be provided in a therapeutically-effective amount for reducing or preventing microbial infection.